Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

July 29, 2022

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2025

Conditions
Diabetes Type 2DKADiabetic Ketoacidosis
Interventions
GENETIC

Genomic analysis

Genetic samples will be collected using a DNA saliva collection kit (Oragene: OG-510) and will be sent for genome-wide genotyping to The Centre for Applied Genomics in The Hospital for Sick Children (SickKids)

Trial Locations (2)

Unknown

RECRUITING

St. Joseph's Health Centre (Unity Health Toronto), Toronto

RECRUITING

Toronto General Hospital (University Health Network), Toronto

All Listed Sponsors
collaborator

Unity Health Toronto

OTHER

collaborator

University Health Network, Toronto

OTHER

collaborator

Sault Area Hospital

OTHER

lead

Mount Sinai Hospital, Canada

OTHER